Derivatives of 5-Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin

Photochemistry and Photobiology

Volumn 67, Issue 1, 1998, Pages 150-154

  Kloek, Joris ^a,b   Akkermans, Willem ^a   Beijersbergen Van Henegouwen, Gerard M J ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DRUG DERIVATIVE; PRODRUG; PROTOPORPHYRIN;

ARTICLE; CELL CULTURE; HUMAN; HYDROLYSIS; METABOLISM; PHOTOCHEMOTHERAPY;

AMINOLEVULINIC ACID; HUMANS; HYDROLYSIS; PHOTOCHEMOTHERAPY; PRODRUGS; PROTOPORPHYRINS; TUMOR CELLS, CULTURED;

EID: 0031603033     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1998.tb05178.x     Document Type: Article

References (35)

1. Kohen, E., R. Santus and J. G. Hirschberg (1995) Photodynamic therapy. In Photobiology (Edited by E. Cohen), pp. 471-489. Academic Press, San Diego.
2. Fisher, A. M. R., A. L. Murphree and C. J. Gomer (1995) Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17, 2-33.
3. Kennedy, J. C. and R. H. Pottier (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B Biol. 14, 275-292.
4. Kennedy, J. C., R. H. Pottier and D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol. 6, 143-148.
5. Peng, Q., K. Berg, J. Moan, M. Kongshaug and J. M. Nesland (1997) 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65, 235-251.
6. Peng, Q., T. Warloe, J. Moan, H. Heyerdahl, H. B. Steen, J. M. Nesland and K.-E. Giercksky (1995) Distribution of 5-aminolevulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinoma. Photochem. Photobiol. 62, 906-913.
7. Cairnduff, F., M. R. Springer, E. J. Hudson, D. V. Ash and S. B. Brown (1994) Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69, 605-608.
8. Szeimies, R.-M., T. Sassy and M. Landthaler (1994) Penetration potency of topical applied δ-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem. Photobiol. 59, 73-76.
9. Loh, C. S., A. J. MacRobert, J. Bedwell, J. Regula, N. Krasner and S. G. Bown (1993) Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br. J. Cancer 68, 41-51.
10. Goff, B. A., R. Bachor, N. Kollias and T. Hasan (1992) Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J. Photochem. Photobiol. B Biol. 15, 239-251.
11. Warloe, T., Q. Peng, H. B. Steen and K.-E. Giercksky (1992) Localization of porphyrins in human basal cell carcinoma and normal skin tissue induced by topical application of 5-aminolevulinic acid. In Photodynamic Therapy and Biomedical Lasers (Edited by P. Spinelli, M. Dal Fante and R. Marchesini), pp. 454-458. Elsevier, Amsterdam.
12. Liu, P., A. S. Nightingale and T. Kurihara-Bergstrom (1993) Variation of human skin permeation in vitro: Ionic vs neutral compounds. Int. J. Pharm. 90, 171-176.
13. Peck, K. D., A. H. Ghanem and W. I. Higuchi (1994) Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharm. Res. 11, 1306-1334.
14. Bundgaard, H. (1985) Design and application of prodrugs. In Designs of Prodrugs (Edited by H. Bundgaard), pp 386-421. Elsevier, New York.
15. Nielsen, N. M. and H. Bundgaard (1988) Glycolamide esters as biolabile prodrugs of carboxylic acid agents: synthesis, stability, bioconversion, and physiochemical properties. J. Pharm. Sci. 77, 285-298.
16. Thomsen, K. F. and H. Bundgaard (1993) Cyclization-activated phenyl carbamate prodrugs for protecting phenols against first-pass metabolism. Int. J. Pharm. 91, 39-49.
17. Bonina, F. P., L. Montenegro, G. Trapani, M. Franco and G. Liso (1995) In vitro evaluation of N-acyllactam esters of indomethacin as dermal prodrugs. Int. J. Pharm. 124, 45-51.
18. Sloan, K. B. and N. Bodor (1982) Hydroxymethyl and acyloxymethyl prodrugs of theophylline: enhanced delivery of polar drugs through skin. Int. J. Pharm. 12, 299-333.
19. Mollgaard, B., A. Hoelgaard and H. Bundgaard (1982) Prodrugs as drug delivery systems XXII. Improved dermal delivery of 5-fluoro-uracil through human skin via N-acyloxymethyl pro-drug derivatives. Int. J. Pharm. 12, 153-162.
20. Chan, Y. and A. L. W. Po (1989) Prodrugs for dermal delivery. Int. J. Pharm. 55, 1-16.
21. Peng, Q., T. Warloe, J. Moan, H. Heyerdahl, H. Steen, K.-E. Giercksky and J. M. Nesland (1995) ALA-derivative induced protoporphyrin IX build-up and distribution in human nodular basal cell carcinoma. Photochem. Photobiol. 61, 82S.
22. Peng, Q., J. Moan, T. Warloe, V. Iani, H. B. Steen, A. Bjørseth and J. M. Nesland (1996) Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J. Photochem. Photobiol. B Biol. 34, 95-96.
23. Kloek, J. and G. M. J. Beijersbergen van Henegouwen (1996) Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. 64, 994-1000.
24. Takeya, H. (1992) Preparation of 5-aminolevulinic acid alkyl esters as herbicides. Chem. Abstr. 116, P 189633m.
25. Hanania, J. and Z. Malik (1992) The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett. 65, 127-133.
26. Kennedy, S. W., A. Lorenzen, C. A. James and B. T. Collins (1993) Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multi-well plate reader. Anal. Biochem. 211, 102-112.
27. Bundgaard, H., A. Buur, S.-C. Chang and V. H. L. Lee (1988) Timolol prodrugs: synthesis, stability and lipophilicity of various alkyl, cycloalkyl and aromatic esters of timolol. Int. J. Pharm. 46, 77-88.
28. Järvinen, T., M. Poikolainen, P. Suhonen, J. Vepsäläinen, S. Alaranta and A. Urtti (1995) Comparison of enzymatic hydrolysis of pilocarpine prodrugs in human plasma, rabbit cornea and butyrylcholinesterase solutions. J. Pharm. Sci. 84, 656-660.
29. Jacob, J. N., V. E. Shashoua, A. Campbell and R. J. Baldessarini (1985) γ-aminobutyric acid esters 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of γ-aminobutyric acid. J. Med. Chem. 28, 106-110.
30. Namane, A., C. Gouyette, M.-P. Fillion and T. Huyn-Dinh (1992) Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J. Med. Chem. 35, 3039-3044.
31. Van Bree, J. B. M. M., A. G. de Boer, M. Danhof and D. D. Breimer (1993) Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system. Pharm. World Sci. 15, 2-9.
32. Garzon-Aburbeh, A., J. H. Poupaert, M. Claesen, P. Dumont and G. Atassi (1983) 1,3-Dipalmoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent. J. Med. Chem. 26, 1200-1203.
33. Friend, D. R. and G. W. Chang (1984) A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J. Med. Chem. 27, 261-266.
34. Nolen, H. W. and D. R. Friend (1994) Menthol-β-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome. Pharm. Res. 11, 1707-1711.
35. Pohl, J., B. Bertram, P. Hilgard, M. R. Nowrousian, J. Stuben and M. Wiessler (1995) D-19575 - a sugar linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemother. Pharmacol. 35, 364-370.